Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cholangiocarcinoma × Trastuzumab × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 318 Neoplasm Metastasis 27 Stomach Neoplasms 25 Breast Neoplasms, Male 23 Neoplasms 15 Inflammatory Breast Neoplasms 11 Brain Neoplasms 10 Esophageal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Urinary Bladder Neoplasms 5 Prostatic Neoplasms 5 Pancreatic Neoplasms 5 Sarcoma 4 Rectal Neoplasms 4 Endometrial Neoplasms 4 Colonic Neoplasms 4 Adenocarcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Triple Negative Breast Neoplasms 3 Salivary Gland Neoplasms 3 Lung Neoplasms 3 HER2-positive Breast Cancer 3 Cardiotoxicity 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Ductal, Breast 3 Adenocarcinoma Of Esophagus 3 Vulvar Neoplasms 2 Vipoma 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2

Interventions

Gemcitabine 34 Cisplatin 20 Oxaliplatin 14 pembrolizumab 11 Capecitabine 11 Fluorouracil 8 Leucovorin 7 Radiofrequency Ablation 6 lenvatinib 5 Panitumumab 5 Bevacizumab 5 Albumin-Bound Paclitaxel 5 durvalumab 4 Nivolumab 4 Irinotecan 4 130-nm albumin-bound paclitaxel 4 tremelimumab 3 Taxes 3 Injections 3 Hepatectomy 3 Drug Therapy 3 trametinib 2 spartalizumab 2 sintilimab 2 pemigatinib 2 derazantinib 2 budigalimab 2 atezolizumab 2 apatinib 2 Stents 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03613168 2021-01-05

BILHER

Asan Medical Center

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡